Article Versions Notes

Anwar AI, Hegazi A-rA, Bhuchakra HP, Nelson JR, Birdsong TL, Fontenot CJ, Zeibo M, Fazal-ur-Rehman MM, Bieber HP, Spring CJ, et al. Pridopidine Mediated Sigma-1 Receptor Activation and Therapeutic Implications in Neurodegenerative Diseases. Neurology International. 2026; 18(8):144. https://doi.org/10.3390/neurolint18080144

Anwar, Ahmed I., Abdul-rahman A. Hegazi, Hamsa Priya Bhuchakra, Joshua R. Nelson, Ty L. Birdsong, Cy J. Fontenot, Majed Zeibo, Moiz M. Fazal-ur-Rehman, Harrison P. Bieber, Claudia J. Spring, and et al. 2026. "Pridopidine Mediated Sigma-1 Receptor Activation and Therapeutic Implications in Neurodegenerative Diseases" Neurology International 18, no. 8: 144. https://doi.org/10.3390/neurolint18080144

Anwar, A. I., Hegazi, A.-r. A., Bhuchakra, H. P., Nelson, J. R., Birdsong, T. L., Fontenot, C. J., Zeibo, M., Fazal-ur-Rehman, M. M., Bieber, H. P., Spring, C. J., Smith, J. L., Hachem, I. A., Singh, T., Sawaya, M. F., Murnane, K. S., & Kaye, A. D. (2026). Pridopidine Mediated Sigma-1 Receptor Activation and Therapeutic Implications in Neurodegenerative Diseases. Neurology International, 18(8), 144. https://doi.org/10.3390/neurolint18080144